Highlights of Past EHA (HOPE) Asia 2019
The 1st edition of the Highlights of Past EHA (HOPE) Asia 2019 took place in Kolkata, India. The meeting was organized in partnership with regional and national societies in Asia.
Dates: August 23-25, 2019
Location: Kolkata, India
Prof John Gribben, President, European Hematology Association (EHA)
Prof Shai Izraeli, Organizing chair, European Hematology Association (EHA)
Prof Gianluca Gaidano, Organizing chair, European Hematology Association (EHA)
Prof Gert Ossenkoppele, Organizing chair, European Hematology Association (EHA)
Prof Rabindra Kumar Jena, Organizing chair, Indian Society of Haematology & Blood Transfusion (ISHBT)
Prof Deepak Kumar Mishra, Scientific committee chair, Eastern Haematology Group (EHG)
Prof Tuphan Kanti Dolai, Organizing secretary, Eastern Haematology Group (EHG)
Prof Sarmila Chandra, Organizing chair, Eastern Haematology Group (EHG)
HOPE Asia 2019 brought the key messages from various fields of hematology of the 24th Congress of EHA to Asia in collaboration with the Eastern Haematology Group (EHG) and the Indian Society of Haematology & Blood Transfusion (ISHBT). Regional and local sessions took place to stimulate and encourage interaction between faculty and participants.
Participants of HOPE Asia 2019 will be able to:
- enhance their knowledge of evidence-based approaches on diagnosis and treatment for hematologic diseases,
- access the latest results on clinical and translational research in hematologic disorders,
- be updated on emerging innovative techniques, diagnostic tools and risk-assessment strategies in hematology and its subspecialties, and
- communicate, collaborate and network with colleagues and representatives of a large international audience from the medical industry.
The HOPE Asia 2019 program covered a variety of topics from the 24th Congress of EHA by key leaders in their fields.
Please find below an overview of the topics covered in the program:
- Acute leukemias
- Chronic leukemias
- Multiple myeloma
- Bleeding & Thrombosis
- Myelodysplastic syndromes
- Myeloproliferative neoplasms
- Aplastic anemia
For the full meeting program, click here.
The abstract program allowed researchers and clinicians from the region to profile the work and share it with an audience of their peers. For more information, click here.
Physicians, clinicians, basic researchers, biologists, trainees, medical students and pharmaceutical companies in Asia interested in the broad field of hematology, specifically those who could not attend the 24th Congress of EHA.
The European Hematology Association awarded travel grants to junior doctors and students from the SAARC countries, who have submitted an abstract, to support them in attending HOPE Asia 2019. For more information, click here.
The meeting was held at the Hyatt Regency Kolkata:
JA-1 Sector III, JA Block, Sector III, Salt Lake City
Kolkata, West Bengal 700098
EHA would like to thank the following regional and national partners for their collaboration. This supports us in realizing our educational goal of bringing the key messages from various fields of hematology of the 24th Congress of EHA to Asia which contributes to the advancement of hematology education and science in the region:
Organizer & sponsorship opportunities
For questions regarding registration and accommodation, please contact Gaurav Sinha at:
M: +91 74886 58371
CIMGlobal India Pvt. Ltd
BB – 31, Ground Floor, Salt Lake City, Sector – I
Near Punjab National Bank, Kolkata – 700064
Would you like to support these type of meetings? Please contact us through email@example.com so we can share the various opportunities with you.
EBAH CME Accreditation
Highlights of Past EHA (HOPE) Asia 2019 is accredited by the European Board for Accreditation in Hematology (EBAH) CME. EBAH CME is the best way for hematologists to master the latest developments within the specialty of hematology. Staying abreast of these scientific developments and keeping in touch with up-to-date views on clinical policy will enable you to raise your professional level, resulting in the best treatment for your patients.